Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
B-DIM in stage I-II prostate cancer before prostatectomy
NCT00888654Phase 2Completed
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Start
- Aug 2009
- Primary completion
- Apr 2014
- Countries
- 1
01
Overview
A Phase 2 trial of 3,3'-diindolylmethane in prostate cancer (PCa), sponsored by Barbara Ann Karmanos Cancer Institute. Started Aug 2009; status: completed.
02
Drugs
3,3'-diindolylmethane
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00888654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00888654.